GD vs LUNG · P/E 22, rev $52.55B vs rev $83.8M
General Dynamics Corporation (GD) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
GD currently screens at market cap $93.69B and trailing P/E 21.8. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the GD and LUNG stock pages for the full models.
Not investment advice.